Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microparticle's Procoagulant Activity to Identify Patients With Cancer and a High Risk for Venous Thrombosis

NCT02095925 is registered in ClinicalTrials.gov with Harry R. Buller as lead sponsor.

NCT NCT02095925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02095925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microparticle's Procoagulant Activity to Identify Patients With Cancer and a High Risk for Venous Thrombosis
Lead sponsor
Harry R. Buller
Phase
Observational
Overall status
Completed
Start date
July 31, 2008
Completion date
January 31, 2017
Enrollment
900 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, deep venous thrombosis, pulmonary embolism